Why Australian Pharmaceutical Industries Ltd (ASX:API) shares have been smashed today

The Australian Pharmaceutical Industries Ltd (ASX:API) share price has been smashed today. Here's why…

a woman

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

One of the worst performers on the market today has been the Australian Pharmaceutical Industries Ltd (ASX: API) share price.

In late morning trade the pharmacy chain operator and wholesaler's shares are down 8.5% to $1.73.

At one stage the shares of the company behind the Priceline pharmacy chain were as much as 10% lower at $1.70.

Why are Australian Pharmaceutical Industries' shares sinking lower?

With no news out of the company, it appears as though a broker note out of Credit Suisse this morning has been the catalyst for the selloff.

According to the note, the broker has downgraded Australian Pharmaceutical Industries' shares to an underperform rating from neutral and cut the price target on them from $1.63 to $1.55.

This price target implies further downside of almost 10.5% over the next 12 months for the company's shares.

Credit Suisse fears that the impressive share price rise since its Clearskincare acquisition in August means its shares are now in danger of a sharp pullback when its releases its results in October.

The company's shares recently hit a 52-week high of $1.94 on the back of its expansion into the skincare market.

Management's belief that the acquisition is highly compelling, complementary, and will lead to a more diversified business with accelerated growth potential appears to have gone down well with investors.

However, Credit Suisse doesn't think investors should get too excited just yet. Especially with the company's core business operating in a challenging environment with both PBS and retail revenues coming under pressure.

The broker believes that its shares could be de-rated next month when the full extent of the tough trading conditions are revealed.

Should you buy the dip?

While I do like that management is diversifying its business, for now I completely agree with Credit Suisse on Australian Pharmaceutical Industries and think investors would be better off staying clear of its shares until after its full year results release.

In addition to this, I think industry peer Sigma Healthcare Ltd (ASX: SIG) would be best avoided. As well as suffering from tough trading conditions, Sigma has just lost one of its biggest supply contracts. I think this earnings gap will be hard to fill.

Instead of these shares, I would consider up and coming healthcare sector peers Paragon Care Ltd (ASX: PGC) and Volpara Health Technologies Ltd (ASX: VHT).

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia owns shares of and has recommended VOLPARA FPO NZ. The Motley Fool Australia has recommended Paragon Care Limited. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Share Fallers

A worried man holds his head and look at his computer.
Share Fallers

Why Graincorp, Light & Wonder, Orica, and Wildcat shares are falling today

These shares are having a tough time on Thursday. But why?

Read more »

A man with his back to the camera holds his hands to his head as he looks to a jagged red line trending sharply downward representing the ASX tech share sell-off today
Share Fallers

Why Insignia, Light & Wonder, Mineral Resources, and Nuix shares are sinking today

These shares are having a difficult time on hump day. But why?

Read more »

A man sits in despair at his computer with his hands either side of his head, staring into the screen with a pained and anguished look on his face, in a home office setting.
Share Fallers

Why Endeavour, Global Data Centre, OFX, and Paladin Energy shares are dropping today

Why are these shares under pressure today? Let's find out.

Read more »

A man sits wide-eyed at a desk with a laptop open and holds one hand to his forehead with an extremely worried look on his face as he reads news of the Bitcoin price falling today on his mobile phone
Share Fallers

ASX 200 uranium stock alert: Paladin Energy shares just crashed 29%!

Paladin Energy shares are under intense selling pressure on Tuesday.

Read more »

A woman with a sad face looks to be receiving bad news on her phone as she holds it in her hands and looks down at it.
Share Fallers

Why Champion Iron, Endeavour, Infomedia, and Resolute Mining shares are sinking today

These shares are starting the week in the red. But why?

Read more »

A man sits in despair at his computer with his hands either side of his head, staring into the screen with a pained and anguished look on his face, in a home office setting.
Share Fallers

Why Arcadium Lithium, Block, Jumbo, and Mineral Resources shares

These shares are ending the week in the red. Why are investors selling them?

Read more »

A woman with short brown hair and wearing a yellow top looks at the camera with a puzzled and shocked look on her face as the Westpac share price goes down for no reason today
Share Fallers

Why Clearview, NAB, Resolute Mining, and Westpac shares are dropping today

These shares are under pressure today. But why?

Read more »

A man looking at his laptop and thinking.
Bank Shares

Why is the Bendigo Bank share price tanking today?

There are a few things that could be driving this bank lower today.

Read more »